BioCardia, Inc. (BCDA) income statement
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.79−0.00 (-0.24%)
Close on Nov 17, 2026Market cap $11.93MP/E –Yield –
BioCardia, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -950.1%
Financial strength
- Current ratio
- 2.09
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 200.3%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 4.42
- Dividend yield
- –
See a number that looks wrong?